Overview

Infant Study of Inhaled Saline in Cystic Fibrosis

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether 7% hypertonic saline (HS) is an effective and safe therapy in infants and young children with CF.
Phase:
N/A
Details
Lead Sponsor:
CF Therapeutics Development Network Coordinating Center
Collaborators:
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Therapeutics
National Heart, Lung, and Blood Institute (NHLBI)